Respected leader brings more than 25 years of valuable experience in the global health industry
SOUTH RIDING, Va., Nov. 21, 2024 /PRNewswire-PRWeb/ -- Slone Partners, a premier executive search and talent advisory firm for life sciences and healthcare organizations, has announced the placement of Amy Nicole Nayar, Pharm.D., M.S., as President and CEO of the Personalized Medicine Coalition (PMC), a 501(c)3-designated nonprofit organization supported by more than 200 businesses, patient advocacy groups, and care delivery institutions. Nayar's tenure will begin on January 1, 2025.
A pioneering leader in the field, Dr. Nayar excels at creating patient-centered change by connecting and mobilizing stakeholders from industry, government, patient communities, and clinical settings. She advocates for integrated healthcare transformation, fostering collaborations, encouraging adaptive thinking, and championing solution-focused initiatives to set new benchmarks in patient care.
Currently, Dr. Nayar serves as Vice President for U.S. Patient Advocacy & Government Affairs at Novartis Gene Therapies. In this capacity, she collaborates to streamline genetic testing and treatment pathways, paving the way for patients to benefit from some of the world's most innovative personalized treatments.
"Amy Nicole Nayar is a tremendously accomplished leader known for her strategic approach to harnassing the resources necessary to drive collective impact, aligning well with PMC's resolve to use patient-centric frameworks and diagnostics to intervene early and improve patient outcomes," said Kim Wilson, Senior Vice President, Executive Search and Partner at Slone Partners. "With an extremely successful track record over more than 25 years in the global health industry, Dr. Nayar will bring a valuable blend of clinical insight and technological understanding to PMC."
"We are excited about this placement as part of our long term partnership with the talented PMC team," said Leslie Loveless, CEO and Managing Partner at Slone Partners. "I cannot overstate the critical nature of PMC's work educating patients and decisionmakers on how personalized medicine can make healthcare far more efficient and effective, and we are honored to partner with them to achieve even greater success in the coming years."
"Under the leadership of Amy Nicole Nayar, the PMC board of directors is confident that the Coalition will significantly expand its influence and impact in education, advocacy, and evidence development for the benefit of patients and health systems around the world," said PMC Board Chairman Lincoln Nadauld, M.D., Ph.D. "We look forward to working with her to strengthen the Coalition and advance personalized medicine."
Nayar earned her Doctor of Pharmacy degree from the University of Michigan and her Master's Degree in Health Outcomes and Pharmacoeconomics from the University of Arizona. She is certified in artificial intelligence from Harvard Medical School and in executive coaching from the City University of New York.
ABOUT SLONE PARTNERS
Founded in 2000, Slone Partners is a premier executive search and talent advisory firm delivering visionary leaders and fractional talent who build and scale amazing life sciences and healthcare organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals. We complement our search and advisory services with a people and culture consulting practice to help our clients and candidates achieve peak performance and drive business success.
Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners' value proposition and our many success stories, visit https://www.slonepartners.com or call 888.784.3422.
ABOUT THE PERSONALIZED MEDICINE COALITION
The Personalized Medicine Coalition, a 501(c)3-designated nonprofit organization comprised of 13 distinct stakeholder groups within health care, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems. PMC provides a forum for achieving consensus and informing policies that support personalized medicine. For more information about PMC, including membership details, please visit http://www.personalizedmedicinecoalition.org.
Media Contact
Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected], www.douggavel.com
SOURCE Slone Partners
Share this article